Amgen Inc. buy Royal Bank of Canada
Start price
04.02.26
/
50%
€282.50
Target price
04.02.27
€304.45
Performance (%)
15.11%
Price
17.07.26
€320.15
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 15.11%. Dividends of €5.04 are taken into consideration when calculating the performance. This prediction currently runs until 04.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 0.565% | 0.565% |
| iShares Core DAX® | -1.111% | 0.196% |
| iShares Nasdaq 100 | -4.346% | -3.249% |
| iShares Nikkei 225® | -6.785% | -7.717% |
| iShares S&P 500 | -1.788% | 0.993% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Royal Bank Of Canada from $335.00 to $360.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat